NEPAD African Western and Southern Networks of Centres of Excellence in Water Sciences

Insight Medbotics Announces World's First FDA-Cleared, MRI-Compatible Robot

Retrieved on: 
Wednesday, September 13, 2023

IGAR is the first and only robotics system designed to work inside an MRI bore to achieve this regulatory clearance.

Key Points: 
  • IGAR is the first and only robotics system designed to work inside an MRI bore to achieve this regulatory clearance.
  • Insight Medbotics has demonstrated IGAR's safety and efficacy through published clinical studies in breast biopsy.
  • Insight Medbotics was subsequently launched as a start-up company by CSii and MDA.
  • With the 510(k) clearance secured, Insight Medbotics will continue to advance IGAR to market.

Asep Inc. Receives Grant from NanoMedicines Innovation Network (NMIN), Funded by the Government of Canada

Retrieved on: 
Saturday, June 24, 2023

The Government of Canada funds NMIN through the Networks of Centres of Excellence (NCE) Program.

Key Points: 
  • The Government of Canada funds NMIN through the Networks of Centres of Excellence (NCE) Program.
  • To date, the Company and its subsidiaries have received over USD $20 million in non-dilutive grant funding from organizations such as the Bill and Melinda Gates Foundation, Genome Canada and UBC.
  • The Company, through its pre-clinical partner, iFyber LLC, has also received funding from the US Army for its novel antibiofilm peptide technology.
  • The grant title is "Pre-clinical evaluation of nanoparticle formulations for the in vivo delivery of anti-biofilm and anti-inflammatory synthetic host defence peptides."

New software for tracking Parkinson's disease symptoms wins Canada-wide competition

Retrieved on: 
Thursday, October 20, 2022

"He came to me with a brilliant idea to help others, and that progressed into a full software which we've developed called PRIMS."

Key Points: 
  • "He came to me with a brilliant idea to help others, and that progressed into a full software which we've developed called PRIMS."
  • How it works: First, the person living with Parkinson's completes an at-home survey to determine their daily living skills.
  • The PRIMS software then assigns a score, based on real-time data, on an internationally recognized Parkinson's scale.
  • For people living with Parkinson's, PRIMS "helps them keep track of those symptoms they are having, from their own personal portal."

New interactive tool aims to help people living with mild dementia stay safe while maintaining their freedom to go where they like

Retrieved on: 
Tuesday, October 18, 2022

The website features an interactive tool that pinpoints a person's risk level for getting lost and then provides strategies tailored to that specific risk level.

Key Points: 
  • The website features an interactive tool that pinpoints a person's risk level for getting lost and then provides strategies tailored to that specific risk level.
  • "Persons living with dementia are at a higher risk of getting lost and going missing.
  • The Guideline simplified the more than 300 types of strategies for persons with dementia at risk of getting lost.
  • The website tool asks six questions to assess anindividual's personal risk level of getting lost whether low, medium or high risk.

Dr. Alex Mihailidis recognised as one of the Healthy Ageing 50 -- 50 leaders working to transform the world to be a better place to grow older

Retrieved on: 
Wednesday, September 28, 2022

The Healthy Ageing 50 is an initiative under the banner of the UN Decade of Healthy Ageing that seeks to honour 50 leaders who are working to foster healthy aging.

Key Points: 
  • The Healthy Ageing 50 is an initiative under the banner of the UN Decade of Healthy Ageing that seeks to honour 50 leaders who are working to foster healthy aging.
  • "I am proud to be recognized as one of the Healthy Ageing 50 50 leaders working to transform the world to be a better place in which to grow older," said Dr. Mihailidis.
  • "It is a great honour to be one of 50 leaders recognized for their efforts to improve the lives of current and future generations of older people."
  • AGE-WELL extends sincere congratulations to Dr. Mihailidis and the other Healthy Ageing 50 leaders selected for their extraordinary achievements in the area of healthy aging.

AGE-WELL announces recipients of its 2022 Emerging Entrepreneur Award

Retrieved on: 
Wednesday, August 17, 2022

TORONTO, Aug. 17, 2022 /CNW/ - The 2022 recipients of AGE-WELL's Emerging Entrepreneur Award are Liam Maaskant, co-developer of a walker with an elevating seat to give older adults greater independence at home, and Anika Munn, co-creator of a smart monitoring system to help older adults feel safer and more comfortable in various living settings.

Key Points: 
  • TORONTO, Aug. 17, 2022 /CNW/ - The 2022 recipients of AGE-WELL's Emerging Entrepreneur Award are Liam Maaskant, co-developer of a walker with an elevating seat to give older adults greater independence at home, and Anika Munn, co-creator of a smart monitoring system to help older adults feel safer and more comfortable in various living settings.
  • The AGE-WELL Emerging Entrepreneur Award supports the development of emerging entrepreneurs to create and grow an innovative startup with potential social and economic impact inCanada.
  • The award is designed to give a new entrepreneur the financial resources, mentorship and training as they focus on making their ideas viable and rapidly deployable in service to older adults and caregivers.
  • "As a new graduate, I could not be more honoured and happier to receive this award.

The AGE-WELL National Impact Challenge is back for startups in Canada's AgeTech sector

Retrieved on: 
Wednesday, August 3, 2022

"The AGE-WELL National Impact Challenge has become a high-profile event for showcasing top innovators in Canada's growing AgeTech sector," says Dr. Alex Mihailidis, Scientific Director and CEO of AGE-WELL, Canada's technology and aging network.

Key Points: 
  • "The AGE-WELL National Impact Challenge has become a high-profile event for showcasing top innovators in Canada's growing AgeTech sector," says Dr. Alex Mihailidis, Scientific Director and CEO of AGE-WELL, Canada's technology and aging network.
  • Through initiatives such as the AGE-WELL National Impact Challenge, AGE-WELL is advancing Canada's leadership in technology-based solutions that support older adults and caregivers everywhere."
  • "We are proud to be a sponsor of the AGE-WELL National Impact Challenge for the second year in a row.
  • To apply or find out more about the AGE-WELL National Impact Challenge, please see the competition main page .

Seeking Canadian innovators for $6.4 million prize to develop life-changing technology for people with dementia

Retrieved on: 
Saturday, July 30, 2022

TORONTO, July 30, 2022 /CNW/ - AGE-WELL is joining forces with Challenge Works to support the new 4.1 million ($6.4 million CAD1) Longitude Prize on Dementia which will reward innovators developing assistive technologies for people living with dementia.

Key Points: 
  • TORONTO, July 30, 2022 /CNW/ - AGE-WELL is joining forces with Challenge Works to support the new 4.1 million ($6.4 million CAD1) Longitude Prize on Dementia which will reward innovators developing assistive technologies for people living with dementia.
  • The 4.1 million Longitude Prize on Dementia will award 3.1 million ($4.8 million CAD) in seed funding and grants to the most promising innovators, with a 1 million ($1.6 million CAD) prize awarded to the winner in early 2026.
  • Funded by Alzheimer's Society - the UK's leading dementia charity - and Innovate UK - the UK government's innovation agency - the Longitude Prize on Dementia is delivered by global challenge prize experts, Challenge Works.
  • To date, it has distributed 84 million ($130 million CAD)in funding and engaged with 12,000 innovators.

Isotopia and CPDC Successfully Deliver First Doses of n.c.a. Lu-177 to North American Customers

Retrieved on: 
Thursday, June 9, 2022

Lu-177 has been successfully transferred into CPDC's GMP facility and that CPDC has shipped its first doses of commercial n.c.a.

Key Points: 
  • Lu-177 has been successfully transferred into CPDC's GMP facility and that CPDC has shipped its first doses of commercial n.c.a.
  • Isotopia is thus adding a new production site in North America at CPDC, strengthening its global footprint in the n.c.a.
  • Lu-177 supply in North America" said Dr. Bruno Paquin, CEO of CPDC, "CPDC and Isotopia are proud to offer this unique value proposition for CPDC's clients and beyond, empowering CPDC to become an all-encompassing radiopharmaceutical CDMO."
  • For more information about Isotopia, please visit: www.isotopia.co.il
    The Centre for Probe Development and Commercialization (CPDC) is located in Hamilton, Ontario, Canada.

AGE-WELL announces nine AgeTech projects to fast track innovations into the real world

Retrieved on: 
Thursday, May 26, 2022

"Our new AIR program is laser-focused on implementing and scaling up validated AgeTech innovations in different settings," said Dr. Alex Mihailidis, Scientific Director and CEO of AGE-WELL, Canada's technology and aging network.

Key Points: 
  • "Our new AIR program is laser-focused on implementing and scaling up validated AgeTech innovations in different settings," said Dr. Alex Mihailidis, Scientific Director and CEO of AGE-WELL, Canada's technology and aging network.
  • The nine projects are led by 10 researchers based at Canadian universities and research centres.
  • Long-term care homes, retirement residences, Indigenous health clinics and private residences are some of the settings in which innovations will be implemented.
  • Older adults and caregivers were involved in the grant review process and will take part in each phase of the AIR projects.